Does DOXORUBICIN Cause Second primary malignancy? 1,151 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,151 reports of Second primary malignancy have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 1.4% of all adverse event reports for DOXORUBICIN.
1,151
Reports of Second primary malignancy with DOXORUBICIN
1.4%
of all DOXORUBICIN reports
494
Deaths
210
Hospitalizations
How Dangerous Is Second primary malignancy From DOXORUBICIN?
Of the 1,151 reports, 494 (42.9%) resulted in death, 210 (18.2%) required hospitalization, and 134 (11.6%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 1,151 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Product use in unapproved indication (3,502)
Nausea (2,925)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
METHOTREXATE (414)
Which DOXORUBICIN Alternatives Have Lower Second primary malignancy Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE